• Rapidly enlarging malignant astrocytic tumor characterized
by necrosis and neovascularity
• Most common of all primary intracranial neoplasms
• Best imaging clue: Thick, irregularly enhancing rind of
neoplastic tissue surrounding necrotic core
• Heterogeneous, hyperintense mass with adjacent tumor
• Necrosis, cysts, hemorrhage, fluid/debris levels, flow voids
• Supratentorial white matter most common location
○ Cerebral hemispheres > brainstem > cerebellum
• Viable tumor extends far beyond signal changes
• Neoplasms: Anaplastic astrocytoma, lymphoma, metastasis
• Tumefactive demyelination, subacute ischemia
• Histology: Necrosis, microvascular proliferation, WHO IV
○ 4 major subtypes = classic, mesenchymal, proneural,
– Primary (de novo) glioblastoma (GBM)
□ 95% of GBMs; most are classical; EGFR amplified,
– Secondary (arises from lower grade astrocytoma)
□ Younger patient; often proneural; IDH1, TP53 often
• Seizures, focal neurologic deficits common
• Peak: 45-75 years, but may occur at any age
• 12-15% intracranial neoplasms, 2/3 of astrocytomas
• Relentless progression, survival often < 1 year
○ Varies with genetic, other factors (e.g., MGMT status)
centrally necrotic infiltrating
frontal and temporal lobes are
area of MR signal abnormality.
No comments:
Post a Comment
اكتب تعليق حول الموضوع